
Work Here?
Teal Health offers an integrated telehealth platform plus an at-home cervical cancer screening kit. It begins with a brief virtual visit and prescription, then sends the Teal Wand self-collection kit to the user’s home, who self-collects a sample and mails it to a certified lab; results are delivered in a patient portal with telehealth follow-up. The Teal Wand is the first FDA-approved at-home self-collection device for cervical cancer screening in the U.S., testing for high-risk HPV with accuracy similar to clinician-collected samples. The company aims to raise cervical cancer screening rates by removing access barriers and making testing convenient for women who are not up-to-date with screening.
Industries
Hardware
Consumer Software
Enterprise Software
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$18.8M
Headquarters
San Francisco, California
Founded
2020
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$18.8M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Health Insurance
Health Savings Account/Flexible Spending Account
Parental Leave
Company Equity
Professional Development Budget
Teal Health secured FDA marketing authorization in May 2025 for its breakthrough device addressing a critical gap in women's health care, specifically cervical cancer screening. The device received FDA Breakthrough Device designation due to its public health importance, as one in four women are behind on screenings. This achievement helped Teal Health raise $23 million in funding.
Find jobs on Simplify and start your career today
Industries
Hardware
Consumer Software
Enterprise Software
Healthcare
Company Size
11-50
Company Stage
Seed
Total Funding
$18.8M
Headquarters
San Francisco, California
Founded
2020
Find jobs on Simplify and start your career today